InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by deVries Tina Marie, Vice-Président Exécutif. Director active across 3 companies, notably Osmotica Pharmaceuticals plc. Cumulatively, 5 filings have been logged. The latest transaction was filed on 18 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations5 total
€7,2825,447 shares@ €1.336827.6% of flow
Ordinary Shares
SEC:0001104659-22-063394:0·
€9,5729,607 shares@ €0.996336.2% of flow
Ordinary Shares
SEC:0001104659-22-007841:0·
€9,5729,607 shares@ €0.9963100.0% of flow
Ordinary Shares
SEC:0001104659-22-007841·
€16,5066,467 shares@ €2.5524100.0% of flow
Ordinary Shares
SEC:0001104659-21-069876·
€16,5066,467 shares@ €2.552450.0% of flow
Ordinary Shares
SEC:0001104659-21-069876:0·
5 of 5 declarations
About deVries Tina Marie
Tina Marie deVries is the EVP of Research & Development at Osmotica Pharmaceuticals plc and RVL Pharmaceuticals plc. She is responsible for leading research initiatives, focusing on innovation in the pharmaceutical sector. Her expertise is essential for the development of new products.
